| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
| 04/06/2000 | WO2000018918A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 04/06/2000 | WO2000018915A2 Membrane-associated organizational proteins |
| 04/06/2000 | WO2000018912A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 04/06/2000 | WO2000018902A1 Method of screening for large offspring syndrome |
| 04/06/2000 | WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases |
| 04/06/2000 | WO2000018804A1 Tie2 agonist antibodies |
| 04/06/2000 | WO2000018801A2 Ncam binding compounds |
| 04/06/2000 | WO2000018764A1 Benzimidazolinyl piperidines as cgrp ligands |
| 04/06/2000 | WO2000018760A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders |
| 04/06/2000 | WO2000018759A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 04/06/2000 | WO2000018749A1 Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments |
| 04/06/2000 | WO2000018724A1 (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 04/06/2000 | WO2000018723A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/06/2000 | WO2000018721A1 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/06/2000 | WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 04/06/2000 | WO2000018437A1 Tie2 antagonist antibodies |
| 04/06/2000 | WO2000018431A1 Chemokine receptor peptide vaccines for treatment and prevention of diabetes |
| 04/06/2000 | WO2000018396A1 HMG-CoA REDUCTASE INHIBITOR-CONTAINING PREPARATIONS |
| 04/06/2000 | WO2000018395A1 Method for preventing or delaying catheter-based revascularization |
| 04/06/2000 | WO2000018373A1 Core tablet for controlled release of gliclazide after oral administration |
| 04/06/2000 | WO1999066914A3 Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-l-carnitine and hypericin |
| 04/06/2000 | WO1999065476A3 COMPOSITIONS FOR INCREASING ENERGY $i(IN VIVO) |
| 04/06/2000 | WO1999061626A3 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase |
| 04/06/2000 | WO1999037294A3 Mitochondria protecting agents for treating mitochondria associated diseases |
| 04/06/2000 | CA2345978A1 Chemokine receptor peptide vaccines for treatment and prevention of diabetes |
| 04/06/2000 | CA2345359A1 Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments |
| 04/06/2000 | CA2345357A1 Benzimidazolinyl piperidines as cgrp ligands |
| 04/06/2000 | CA2345108A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/06/2000 | CA2344658A1 Human kinesin-like motor protein |
| 04/06/2000 | CA2344107A1 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 04/06/2000 | CA2344104A1 Method of screening for large offspring syndrome |
| 04/06/2000 | CA2343975A1 Ncam binding compounds |
| 04/06/2000 | CA2343939A1 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 04/06/2000 | CA2343934A1 Short peptides which selectively modulate the activity of protein kinases |
| 04/06/2000 | CA2343696A1 Membrane-associated organizational proteins |
| 04/06/2000 | CA2338442A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 04/06/2000 | CA2311462A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 04/06/2000 | CA2285151A1 Novel heparin binding peptides |
| 04/05/2000 | EP0989993A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 04/05/2000 | EP0989853A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/05/2000 | EP0989852A1 Method for treating atherosclerosis with an mpt inhibitor and cholesterol lowering drugs |
| 04/05/2000 | EP0874812B1 Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof |
| 04/05/2000 | EP0777672A4 Amino acid chelates having improved palatability |
| 04/05/2000 | EP0738147B1 Application of riluzole in the treatment of mitochondrial diseases |
| 04/05/2000 | EP0734371B1 Novel retinoid conjugate compounds and methods for treating skin aging |
| 04/05/2000 | CN1249748A Small molecules useful in treatment of inflamatory disease |
| 04/05/2000 | CN1249688A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/05/2000 | CN1249680A Diabetes remedies |
| 04/04/2000 | US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors |
| 04/04/2000 | US6046340 Imidazole containing pseudodipeptide product and compositions containing the same |
| 04/04/2000 | US6046331 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
| 04/04/2000 | US6046317 For screening for carrier status and diagnosis of predisposition for increased serum cholesterol or low density lipoprotein cholesterol level in humans |
| 04/04/2000 | US6046237 Non-β-oxidizable fatty acid analogues, their uses as therapeutic active medicaments |
| 04/04/2000 | US6046227 Useful in the treatment of type ii diabetes and obesity; a substituted pyrazine compound |
| 04/04/2000 | US6046222 Preventing or delaying the noninsulin dependent diabetes mellitus comprising administering to a host suffering from polycystic ovary syndrom or suffered from gestational diabetes a therapeutically effective amount of pioglitazone |
| 04/04/2000 | US6046220 Propynyl or dienyl biaromatic compounds |
| 04/04/2000 | US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/04/2000 | US6046204 Treatment of immunosuppressive, autoimmune, inflammatory, proliferative and hyperproliferative diseases including cancer, and of cutaneous manifestations of immunologically mediated diseases, for example rheumatoid arthritis, lupus |
| 04/04/2000 | US6046184 Medicament for treating obesity and improving lipid metabolism |
| 04/04/2000 | US6046166 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 04/04/2000 | US6046030 For the treatment of neurological disorders such as alzheimer's disease, multiple sclerosis and abnormal neural development; endocrine disorders such as diabetes; and heart disease, among others and diagnostic assays for such |
| 04/04/2000 | US6046022 Methods and compositions employing red rice fermentation products |
| 04/04/2000 | US6045826 Antioxidant/antiaging medicinal or cosmetic mixture for skin disorder prophylaxis |
| 03/30/2000 | WO2000017641A1 Gpr10 as a target for identifying weight modulating compounds |
| 03/30/2000 | WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 03/30/2000 | WO2000017354A1 Human isre-binding protein |
| 03/30/2000 | WO2000017353A1 Ucp4 |
| 03/30/2000 | WO2000017328A2 Fibrils |
| 03/30/2000 | WO2000017222A1 31 human secreted proteins |
| 03/30/2000 | WO2000017211A1 Phosphonic acids derivatives as inhibitors of ptp-1b |
| 03/30/2000 | WO2000017204A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | WO2000017202A1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 03/30/2000 | WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 03/30/2000 | WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 03/30/2000 | WO2000017182A1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
| 03/30/2000 | WO2000017176A2 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 03/30/2000 | WO2000017173A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 03/30/2000 | WO2000017167A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 03/30/2000 | WO2000017166A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 03/30/2000 | WO2000017165A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 03/30/2000 | WO2000017164A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 03/30/2000 | WO2000017159A1 Arylsulfonanilide ureas |
| 03/30/2000 | WO2000016797A2 Use of glp-1 or analogs in treatment of stroke |
| 03/30/2000 | WO2000016782A1 Pharmaceutical compositions of vanadium biguanide complexes and their use |
| 03/30/2000 | WO2000016781A1 Chk1 kinase inhibitors |
| 03/30/2000 | WO2000016749A1 Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications |
| 03/30/2000 | WO1999066918A9 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 03/30/2000 | WO1999040932A9 Mixed micellar pharmaceutical delivery system and method of preparation |
| 03/30/2000 | WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 03/30/2000 | DE19845830A1 Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln Aminoalkyl-3,4-dihydroquinoline derivatives and their use in medicaments |
| 03/30/2000 | DE19844547A1 Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Polycyclic Dihydrothiazole, processes for their preparation and their use as medicaments |
| 03/30/2000 | CA2345088A1 Gpr10 as a target for identifying weight modulating compounds |
| 03/30/2000 | CA2344927A1 Phosphonic acids derivatives as inhibitors of ptp-1b |
| 03/30/2000 | CA2344657A1 Human isre-binding protein |
| 03/30/2000 | CA2344556A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 03/30/2000 | CA2344262A1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 03/30/2000 | CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |